Citations (38)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Alicia Algeciras-Schimnich. (2018) Thyroglobulin measurement in the management of patients with differentiated thyroid cancer. Critical Reviews in Clinical Laboratory Sciences 55:3, pages 205-218.
Read now
Read now
Carol Evans, Sarah Tennant & Petros Perros. (2016) Serum thyroglobulin in the monitoring of differentiated thyroid cancer. Scandinavian Journal of Clinical and Laboratory Investigation 76:sup245, pages S119-S123.
Read now
Read now
Articles from other publishers (36)
Luca Giovanella, Federica D’Aurizio, Alicia Algeciras-Schimnich, Rainer Görges, Petra Petranovic Ovcaricek, R Michael Tuttle, W Edward Visser, Frederik A Verburg, Martyna Borowczyk, Luca Chiovato, Leonidas Duntas, Thyroid Section, Ulla Feldt-Rasmussen, Luisa Knappe, Laurence Leenhardt, Flavia Magri, Harald Rimmele & Ettore Seregni. (2023) Thyroglobulin and thyroglobulin antibody: an updated clinical and laboratory expert consensus. European Journal of Endocrinology 189:2, pages R11-R27.
Crossref
Crossref
Luca Giovanella, Lisa Milan, Wolfgang Roll, Manuel Weber, Simone Schenke, Michael Kreissl, Alexis Vrachimis, Kim Pabst, Tuncel Murat, Petra Petranovic Ovcaricek, Burkhard Riemann, Luca Ceriani, Alfredo Campenni & Rainer Görges. (2023) Postoperative thyroglobulin as a yard-stick for radioiodine therapy: decision tree analysis in a European multicenter series of 1317 patients with differentiated thyroid cancer. European Journal of Nuclear Medicine and Molecular Imaging 50:9, pages 2767-2774.
Crossref
Crossref
Alberto Signore, Chiara Lauri, Arianna Di Paolo, Valeria Stati, Giuliano Santolamazza, Gabriela Capriotti, Daniela Prosperi, Anna Tofani, Stefano Valabrega & Giuseppe Campagna. (2023) Predictive Role of Serum Thyroglobulin after Surgery and before Radioactive Iodine Therapy in Patients with Thyroid Carcinoma. Cancers 15:11, pages 2976.
Crossref
Crossref
Carol Evans, Johannes Lotz, Maria Bhandari, Rowan T. Hellier, Xiao Yan Wang, Rosemarie Lott, Karl J. Lackner, Robert Müller & Vathany Kulasingam. (2022)
Multi‐center evaluation of the highly sensitive Abbott
ARCHITECT
and Alinity thyroglobulin chemiluminescent microparticle immunoassay
. Journal of Clinical Laboratory Analysis 36:9.
Crossref
Crossref
Lebriz Uslu-Beşli. 2022. Biomarkers in Medicine. Biomarkers in Medicine
77
94
.
Deepshikha Shahdeo & Sonu Gandhi. 2022. Biosensor Based Advanced Cancer Diagnostics. Biosensor Based Advanced Cancer Diagnostics
179
196
.
Araceli Gago-Arias, Sara Neira, Filippo Terragni & Juan Pardo-Montero. (2021) A Mathematical Model of Thyroid Disease Response to Radiotherapy. Mathematics 9:19, pages 2365.
Crossref
Crossref
Tatsuya Hirokawa, Yuu Arimasu, Yoko Nakazato, Tomohiro Chiba, Masachika Fujiwara & Hiroshi Kamma. (2020)
Effect of single‐nucleotide polymorphism in
TERT
promoter on follicular thyroid tumor development
. Pathology International 70:4, pages 210-216.
Crossref
Crossref
Luca Giovanella. (2020) Circulating biomarkers for the detection of tumor recurrence in the postsurgical follow-up of differentiated thyroid carcinoma. Current Opinion in Oncology 32:1, pages 7-12.
Crossref
Crossref
Luca Giovanella, Frederik A. Verburg, Pierpaolo Trimboli, Mauro Imperiali, Franco Keller & Luca Ceriani. (2019)
Measuring thyroglobulin in patients with thyroglobulin autoantibodies: evaluation of the clinical impact of BRAHMS Kryptor
®
Tg-minirecovery test in a large series of patients with differentiated thyroid carcinoma
. Clinical Chemistry and Laboratory Medicine (CCLM) 57:8, pages 1185-1191.
Crossref
Crossref
Stefan K. G. Grebe. 2019. The Thyroid and Its Diseases. The Thyroid and Its Diseases
129
159
.
Shireen Fatemi & Carole Spencer. 2018. Practical Management of Thyroid Cancer. Practical Management of Thyroid Cancer
155
186
.
Luca Giovanella, Federica D’Aurizio, Renato Tozzoli, Camilla Schalin-Jantti & Ulla Feldt-Rasmussen. 2018. Atlas of Thyroid and Neuroendocrine Tumor Markers. Atlas of Thyroid and Neuroendocrine Tumor Markers
65
91
.
F. D’Aurizio, P. Metus, A. Ferrari, B. Caruso, R. Castello, D. Villalta, A. Steffan, K. Gaspardo, F. Pesente, N. Bizzaro, E. Tonutti, S. Valverde, C. Cosma, M. Plebani & R. Tozzoli. (2017) Definition of the upper reference limit for thyroglobulin antibodies according to the National Academy of Clinical Biochemistry guidelines: comparison of eleven different automated methods. Autoimmunity Highlights 8:1.
Crossref
Crossref
P Trimboli, V Zilioli, M Imperiali, L Ceriani & L Giovanella. (2017) High-sensitive basal serum thyroglobulin 6–12 months after thyroid ablation is strongly associated with early response to therapy and event-free survival in patients with low-to-intermediate risk differentiated thyroid carcinomas. European Journal of Endocrinology 176:5, pages 497-504.
Crossref
Crossref
Pierpaolo Trimboli, Federica D’Aurizio, Renato Tozzoli & Luca Giovanella. (2017) Measurement of thyroglobulin, calcitonin, and PTH in FNA washout fluids. Clinical Chemistry and Laboratory Medicine (CCLM) 55:7.
Crossref
Crossref
Ganesan Padmavathi, Devivasha Bordoloi, Kishore Banik & Ajaikumar B. Kunnumakkara. 2017. Next Generation Point-of-care Biomedical Sensors Technologies for Cancer Diagnosis. Next Generation Point-of-care Biomedical Sensors Technologies for Cancer Diagnosis
1
29
.
Jennifer M. Perkins. 2017. Management of Thyroid Nodules and Differentiated Thyroid Cancer. Management of Thyroid Nodules and Differentiated Thyroid Cancer
331
350
.
Josef Machac. (2016) Thyroid Cancer in Pediatrics. Endocrinology and Metabolism Clinics of North America 45:2, pages 359-404.
Crossref
Crossref
Yujue Li, Tinghong Ye, Fangfang Yang, Mingxing Hu, Libo Liang, He He, Zhipeng Li, Anqi Zeng, Yali Li, Yuqin Yao, Yongmei Xie, Zhenmei An & Shuangqing Li. (2016) Punica granatum (pomegranate) peel extract exerts potent antitumor and anti-metastasis activity in thyroid cancer. RSC Advances 6:87, pages 84523-84535.
Crossref
Crossref
Carole Spencer, Ivana Petrovic, Shireen Fatemi & Jonathan LoPresti. (2014) Serum Thyroglobulin (Tg) Monitoring of Patients with Differentiated Thyroid Cancer Using Sensitive (Second-Generation) Immunometric Assays Can Be Disrupted by False-Negative and False-Positive Serum Thyroglobulin Autoantibody Misclassifications. The Journal of Clinical Endocrinology & Metabolism 99:12, pages 4589-4599.
Crossref
Crossref
Carole Spencer, Jonathan LoPresti & Shireen Fatemi. (2014) How sensitive (second-generation) thyroglobulin measurement is changing paradigms for monitoring patients with differentiated thyroid cancer, in the absence or presence of thyroglobulin autoantibodies. Current Opinion in Endocrinology, Diabetes & Obesity 21:5, pages 394-404.
Crossref
Crossref
L. Giovanella, P. M. Clark, L. Chiovato, L. Duntas, R. Elisei, U. Feldt-Rasmussen, L. Leenhardt, M. Luster, C. Schalin-Jantti, M. Schott, E. Seregni, H. Rimmele, J. Smit & F. A. Verburg. (2014) DIAGNOSIS OF ENDOCRINE DISEASE: Thyroglobulin measurement using highly sensitive assays in patients with differentiated thyroid cancer: a clinical position paper. European Journal of Endocrinology 171:2, pages R33-R46.
Crossref
Crossref
Luca Giovanella, Giorgio Treglia, Ramin Sadeghi, Pierpaolo Trimboli, Luca Ceriani & Frederik A. Verburg. (2014) Unstimulated Highly Sensitive Thyroglobulin in Follow-up of Differentiated Thyroid Cancer Patients: A Meta-Analysis. The Journal of Clinical Endocrinology & Metabolism 99:2, pages 440-447.
Crossref
Crossref
Yuki MORI, Takashi KOSHIKAWA, Junko OZEKI, Noriko SHIBATA, Nanae UEDA, Ei-ichi SASAKI, Yoshiko MURAKAMI, Waki HOSODA, Yasushi YATABE & Yasuhisa HASEGAWA. (2014) Significance of serum thyrotropin concentration in patients with negative diagnosis of thyroid fine-needle aspiration cytology. The Journal of the Japanese Society of Clinical Cytology 53:5, pages 356-361.
Crossref
Crossref
Frederik A. VerburgMarkus LusterCristina CupiniLuca ChiovatoLeonidas DuntasRossella EliseiUlla Feldt-RasmussenHarald RimmeleEttore SeregniJohannes W.A. SmitChristian TheimerLuca Giovanella. (2013) Implications of Thyroglobulin Antibody Positivity in Patients with Differentiated Thyroid Cancer: A Clinical Position Statement. Thyroid 23:10, pages 1211-1225.
Crossref
Crossref
Abhijeet Waghray, Mira Milas, Kavita Nyalakonda & Allan E. Siperstein. (2013) Falsely Low Parathyroid Hormone Secondary to Biotin Interference: A Case Series. Endocrine Practice 19:3, pages 451-455.
Crossref
Crossref
Luca Giovanella, Mauro Imperiali, Frederik A. Verburg & Luca Ceriani. (2013)
Evaluation of the BRAHMS Kryptor
®
Thyroglobulin Minirecovery Test in patients with differentiated thyroid carcinoma
. Clinical Chemistry and Laboratory Medicine (CCLM) 51:2, pages 449-453.
Crossref
Crossref
Luca Giovanella, Massimo Bongiovanni & Pierpaolo Trimboli. (2013) Diagnostic value of thyroglobulin assay in cervical lymph node fine-needle aspirations for metastatic differentiated thyroid cancer. Current Opinion in Oncology 25:1, pages 6-13.
Crossref
Crossref
Luca Giovanella, Emanuela Toffalori, Renato Tozzoli, Marco Caputo, Luca Ceriani & Frederik A. Verburg. (2011) Multiplexed immunoassay of thyroglobulin autoantibodies in patients with differentiated thyroid carcinoma. Head & Neck 34:10, pages 1369-1371.
Crossref
Crossref
Luca Giovanella, Mauro Imperiali, Anna Ferrari, Alessia Palumbo, Lino Furlani, Maria Stella Graziani & Roberto Castello. (2012) Serum thyroglobulin reference values according to NACB criteria in healthy subjects with normal thyroid ultrasound. Clinical Chemistry and Laboratory Medicine 50:5.
Crossref
Crossref
Alicia Algeciras-SchimnichMichael A. LashoKarl M. NessLynn A. CherykStefan K.G. Grebe. (2011) The Roche Elecsys and Siemens-Centaur Thyroglobulin Autoantibody Assays Show Comparable Clinical Performance to the Recently Unavailable Beckman-Coulter Access Thyroglobulin Autoantibody Assay in Identifying Samples with Potentially False-Low Thyroglobulin Measurements Due to Thyroglobulin Autoantibody Interference. Thyroid 21:7, pages 813-814.
Crossref
Crossref
Pasqualino Malandrino, Adele Latina, Salvatore Marescalco, Angela Spadaro, Concetto Regalbuto, Rosa Anna Fulco, Claudia Scollo, Riccardo Vigneri & Gabriella Pellegriti. (2011) Risk-Adapted Management of Differentiated Thyroid Cancer Assessed by a Sensitive Measurement of Basal Serum Thyroglobulin. The Journal of Clinical Endocrinology & Metabolism 96:6, pages 1703-1709.
Crossref
Crossref
Luca Giovanella & Luca Ceriani. (2011) Comparison of thyroglobulin antibody interference in first- and second-generation thyroglobulin immunoassays. Clinical Chemistry and Laboratory Medicine 49:6.
Crossref
Crossref
Kendall W. Cradic, Dragana Milosevic, Anne M. Rosenberg, Lori A. Erickson, Bryan McIver & Stefan K. G. Grebe. (2009)
Mutant
BRAF
T1799A Can Be Detected in the Blood of Papillary Thyroid Carcinoma Patients and Correlates with Disease Status
. The Journal of Clinical Endocrinology & Metabolism 94:12, pages 5001-5009.
Crossref
Crossref
Cristina Familiar, Inmaculada Moraga, Teresa Antón, Manuel ángel Gargallo, Araceli Ramos, Ángel luis Marco, Mariano Villa & María ángeles Tapia. (2009) Factores relacionados con la persistencia de la enfermedad a los 5 años del diagnóstico de cáncer diferenciado de tiroides: estudio de 63 pacientes. Endocrinología y Nutrición 56:7, pages 361-368.
Crossref
Crossref